Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-24-042124

Director acquired 446 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2024-09-03 Other acquisition 10b5-1 +25 $1.38 $35 27,883 D
Young Caroline Director 2024-09-04 Other acquisition 10b5-1 +23 $1.35 $31 27,906 D
Young Caroline Director 2024-09-05 Other acquisition 10b5-1 +23 $1.28 $29 27,929 D
Young Caroline Director 2024-09-06 Other acquisition 10b5-1 +6 $1.30 $8 27,935 D
Young Caroline Director 2024-09-09 Other acquisition 10b5-1 +25 $1.33 $33 27,960 D
Young Caroline Director 2024-09-10 Other acquisition 10b5-1 +15 $1.30 $20 27,975 D
Young Caroline Director 2024-09-11 Other acquisition 10b5-1 +24 $1.35 $32 27,999 D
Young Caroline Director 2024-09-12 Other acquisition 10b5-1 +25 $1.35 $34 28,024 D
Young Caroline Director 2024-09-13 Other acquisition 10b5-1 +25 $1.30 $33 28,049 D
Young Caroline Director 2024-09-16 Other acquisition 10b5-1 +25 $1.30 $33 28,074 D
Young Caroline Director 2024-09-17 Other acquisition 10b5-1 +25 $1.30 $33 28,099 D
Young Caroline Director 2024-09-18 Other acquisition 10b5-1 +25 $1.30 $33 28,124 D
Young Caroline Director 2024-09-19 Other acquisition 10b5-1 +25 $1.29 $32 28,149 D
Young Caroline Director 2024-09-20 Other acquisition 10b5-1 +25 $1.30 $33 28,174 D
Young Caroline Director 2024-09-23 Other acquisition 10b5-1 +25 $1.25 $31 28,199 D
Young Caroline Director 2024-09-24 Other acquisition 10b5-1 +7 $1.22 $9 28,206 D
Young Caroline Director 2024-09-25 Other acquisition 10b5-1 +20 $1.29 $26 28,226 D
Young Caroline Director 2024-09-26 Other acquisition 10b5-1 +25 $1.24 $31 28,251 D
Young Caroline Director 2024-09-27 Other acquisition 10b5-1 +22 $1.24 $27 28,273 D
Young Caroline Director 2024-09-30 Other acquisition 10b5-1 +31 $1.36 $42 28,304 D
Loading xslF345X05/wk-form4_1727986112.xml…